United Therapeutics Corporation (UTHR) — Cash Flow-to-Debt Ratio
United Therapeutics Corporation (UTHR) has a Cash Flow-to-Debt Ratio of 0.74x as of September 2025, meaning its operating cash flow of $562.10 Million could theoretically repay 1% of its total liabilities ($760.90 Million) in one year. Explore United Therapeutics Corporation long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
United Therapeutics Corporation Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for United Therapeutics Corporation across 27 annual periods. Also explore how large is United Therapeutics Corporation's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for United Therapeutics Corporation (1998–2024)
Year-by-year debt coverage analysis for United Therapeutics Corporation. For market capitalisation and broader financial context, see United Therapeutics Corporation (UTHR) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.44x | $1.33 Billion | $920.00 Million | ▲ +74.4% |
| 2023 | 0.83x | $978.00 Million | $1.18 Billion | ▲ +28.6% |
| 2022 | 0.64x | $802.50 Million | $1.25 Billion | ▲ +30.1% |
| 2021 | 0.49x | $598.20 Million | $1.21 Billion | ▼ -20.2% |
| 2020 | 0.62x | $755.70 Million | $1.22 Billion | ▲ +439.8% |
| 2019 | -0.18x | $-206.60 Million | $1.13 Billion | ▼ -114.3% |
| 2018 | 1.27x | $778.40 Million | $612.40 Million | ▲ +108.4% |
| 2017 | 0.61x | $474.20 Million | $777.60 Million | ▼ -56.1% |
| 2016 | 1.39x | $643.60 Million | $463.40 Million | ▲ +112.2% |
| 2015 | 0.65x | $382.80 Million | $584.80 Million | ▲ +14.0% |
| 2014 | 0.57x | $355.30 Million | $618.84 Million | ▲ +5.7% |
| 2013 | 0.54x | $425.27 Million | $783.26 Million | ▼ -10.8% |
| 2012 | 0.61x | $323.63 Million | $531.73 Million | ▲ +38.6% |
| 2011 | 0.44x | $250.19 Million | $569.59 Million | ▲ +13.7% |
| 2010 | 0.39x | $211.53 Million | $547.75 Million | ▲ +54.3% |
| 2009 | 0.25x | $99.72 Million | $398.54 Million | ▲ +285.0% |
| 2008 | -0.14x | $-49.20 Million | $363.62 Million | ▼ -180.5% |
| 2007 | 0.17x | $48.95 Million | $291.23 Million | ▼ -6.8% |
| 2006 | 0.18x | $49.39 Million | $273.94 Million | ▼ -93.2% |
| 2005 | 2.65x | $43.17 Million | $16.31 Million | ▲ +97.7% |
| 2004 | 1.34x | $20.78 Million | $15.52 Million | ▲ +283.5% |
| 2003 | -0.73x | $-8.56 Million | $11.74 Million | ▲ +57.7% |
| 2002 | -1.72x | $-22.26 Million | $12.91 Million | ▲ +30.3% |
| 2001 | -2.47x | $-38.90 Million | $15.72 Million | ▼ -26.5% |
| 2000 | -1.96x | $-31.11 Million | $15.91 Million | ▲ +48.0% |
| 1999 | -3.76x | $-23.70 Million | $6.30 Million | ▲ +21.6% |
| 1998 | -4.80x | $-9.60 Million | $2.00 Million | — |